Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.60 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.58 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.58 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.58 |
| ▸ | CPB2 | Q96IY4 | 4/20 | 0.52 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.48 |
| ▸ | KDM4A | O75164 | 2/20 | 0.48 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.48 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.48 |
| ▸ | TET3 | O43151 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | PLG | P00747 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL168957 | 1.00 | GSR (0.60) | GSRGPR84RNPEPFFAR1CPB2 | |
| SCHEMBL17262908 | 1.00 | GSR (0.60) | GSRGPR84RNPEPFFAR1CPB2 | |
| SCHEMBL7027171 | 0.98 | GPR84 (0.61) | GSRGPR84RNPEPFFAR1CPB2 | |
| SCHEMBL7874857 | 0.98 | GPR84 (0.61) | GSRGPR84RNPEPFFAR1CPB2 | |
| SCHEMBL7925235 | 0.98 | GPR84 (0.61) | GSRGPR84RNPEPFFAR1CPB2 | |
| SCHEMBL4820853 | 0.92 | — | — | |
| SCHEMBL3347601 | 0.92 | — | — | |
| SCHEMBL4819961 | 0.92 | — | — | |
| SCHEMBL28089828 | 0.88 | GPR84 (0.81) | GSRGPR84FFAR1MEN1ALDH1A1 | |
| SCHEMBL11651698 | 0.87 | GPR84 (0.71) | GSRGPR84FFAR1TET2KDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107299072-A | Engineering bacterium and application thereof | 江南大学 | 2017-10-27 | — | — | CN | claimed |
| EP-1117720-A4 | POLYESTER ANALOGUE OF POLY-L-LYSINE AS A SOLUBLE, BIODEGRADABLE GENE DELIVERY CARRIER | EXPRESSION GENETICS INC (US) | 2001-11-14 | — | — | EP | claimed |
| EP-1117720-A1 | POLYESTER ANALOGUE OF POLY-L-LYSINE AS A SOLUBLE, BIODEGRADABLE GENE DELIVERY CARRIER | Expression Genetics, Inc. (US) | 2001-07-25 | — | — | EP | claimed |
| US-6217912-B1 | POLY((4-AMINOBUTYL-)GLYCOLIC ACID | EXPRESSION GENETICS, INC. | 2001-04-17 | — | — | US | claimed |
| WO-2000002950-A9 | POLYESTER ANALOGUE OF POLY-L-LYSINE AS A SOLUBLE, BIODEGRADABLE GENE DELIVERY CARRIER | EXPRESSION GENETICS INC (US) | 2000-07-20 | — | — | WO | claimed |
| WO-2000002950-A1 | POLYESTER ANALOGUE OF POLY-L-LYSINE AS A SOLUBLE, BIODEGRADABLE GENE DELIVERY CARRIER | EXPRESSION GENETICS, INC. (US) | 2000-01-20 | — | — | WO | claimed |
| US-20250206782-A1 | BIOLOGICAL POLYMERS | RES & INNOVATION UK (GB) | 2025-06-26 | — | — | US | disclosed |
| US-11911488-B2 | Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy | THE JOHNS HOPKINS UNIVERSTY (US) | 2024-02-27 | — | — | US | disclosed |
| CN-117551696-A | Composition for transfecting nucleic acid molecules into cells comprising triazole compounds grafted onto cationic polymers and uses thereof | 宝利普拉斯生物转染公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-114901316-B | Composition for transfecting nucleic acid molecules into cells comprising triazole compounds grafted onto cationic polymers and uses thereof | 宝利普拉斯生物转染公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-117440824-A | RNA vaccine against SARS-CoV-2 variants | 库瑞瓦格欧洲公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-117337330-A | TMEM173 saRNA compositions and methods of use | 米纳治疗有限公司 | 2024-01-02 | — | — | CN | disclosed |
| WO-2023183906-A2 | COMPOSITIONS AND METHODS FOR ENHANCING INTRA-MITOCHONDRIAL PROTEIN TRANSLATION AND OXIDATIVE PHOSPHORYLATION | THE BROAD INSTITUTE, INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| US-4703043-A | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensive | E. R. SQUIBB & SONS, INC. (US) | 1987-10-27 | — | — | US | disclosed |
| EP-0239109-A2 | Phosphonate angiotensin converting enzyme inhibitors | E.R. Squibb & Sons, Inc. (US) | 1987-09-30 | — | — | EP | disclosed |
| US-4686298-A | Intermediates for alpha-acyloxy phosphonate angiotensin converting enzyme inhibitors | E. R. SQUIBB & SONS, INC. (US) | 1987-08-11 | — | — | US | disclosed |
| CN-87100055-A | Orally active phosphonyl hydroxyacyl proline and preparation method thereof | — | 1987-08-05 | — | — | CN | disclosed |
| EP-0229520-A1 | Orally active phosphonyl hydroxyacyl prolines and processes for preparing phosphonyl hydroxyacyl prolines | E.R. Squibb & Sons, Inc. (US) | 1987-07-22 | — | — | EP | disclosed |
| US-4670422-A | HYPOTENSIVE AGENT, ANALGESICS | E. R. SQUIBB & SONS, INC. (US) | 1987-06-02 | — | — | US | disclosed |
| US-4616005-A | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives | E. R. SQUIBB & SONS, INC. (US) | 1986-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11911488-B2 | Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy | FOLH1, PSMA3, PSMA7 | GSR 1828/4885GPR84 452/4885RNPEP 226/4885 |
| US-20250206782-A1 | BIOLOGICAL POLYMERS | NSUN3, AARS1, TARBP1 | GSR 3182/4885GPR84 4040/4885RNPEP 62/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.